Calmark supplies products to Global Health Labs

Report this content

Calmark Sweden AB announce today that they deliver a platform with associated test cassettes to Global Health Labs in Seattle, WA, USA. Global Health Labs is a non-profit company fully funded by Gates Ventures (Bill Gates' private investment fund), and partners with the Bill & Melinda Gates Foundation and other cross-sector leaders to develop health technology solutions. Right now they are investigating all products in the world that are NEST360 certified.

Global Health Labs is primarily an organization that develops and improves products for low-income countries. They have no manufacturing or sales of their own but are affiliated with the Bill & Melinda Gates Foundation.

"We are happy that Global Heath Lab is showing interest in our product," comments CEO Anna Söderlund. "We look forward to a possible future collaboration."

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

For more information about Calmark Sweden AB, please contact:

Anna Söderlund, CEO
Telefon: +46 70 214 98 93
E-post: anna.soderlund@calmark.se 
www.calmark.se 

Calmark Sweden AB is a medical technology company that manufactures and markets a point-of-care (POC) analysis method with easier and faster diagnostics of medical conditions in newborns. The unique test platform consists of a portable instrument and test cassettes for various biomarkers. The first test, Neo-Bilirubin, is CE marked and measures the bilirubin level in whole blood for jaundice detection in newborns. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter care chains. In less developed healthcare systems, the product offers a decision support which is currently lacking, since the access to hospital laboratories often is limited. Calmark aims to become the global leader in POC diagnostics for newborns and, in the long term, to offer all relevant tests for the first period of life. The B share is listed on the Spotlight Stock Market and is traded under the CALMA B ticker. Read more at www.calmark.se/eng/home.  

Tags:

Subscribe

Documents & Links